Cargando…
Correction: CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435246/ https://www.ncbi.nlm.nih.gov/pubmed/30962965 http://dx.doi.org/10.1136/esmoopen-2018-000368corr1 |
Ejemplares similares
-
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
por: Preusser, Matthias, et al.
Publicado: (2018) -
Round table discussion
por: CERN. Geneva
Publicado: (2021) -
Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion
por: Berghoff, Anna S., et al.
Publicado: (2019) -
Discussion and Round Table Presentation
Publicado: (1991) -
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
por: Banerjee, Susana, et al.
Publicado: (2020)